First Trust NYSE Arca Biotechnology Index Fund
233 hedge funds and large institutions have $908M invested in First Trust NYSE Arca Biotechnology Index Fund in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 91 reducing their positions, and 35 closing their positions.
70% more call options, than puts
Call options by funds: $1.97M | Put options by funds: $1.16M
1% less capital invested
Capital invested by funds: $921M → $908M (-$13.1M)
6% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 35
1% less funds holding
Funds holding: 236 → 233 (-3)
1.51% less ownership
Funds ownership: 47.58% → 46.07% (-1.5%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
43% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 91
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIG
McGuire Investment Group
Wakefield,
Rhode Island
|
+$5.1M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$4.51M |
| 3 |
FTUS
Flow Traders U.S.
New York
|
+$3.85M |
| 4 |
Morgan Stanley
New York
|
+$2.86M |
| 5 |
TC
TownSquare Capital
Provo,
Utah
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$8.72M |
| 2 |
KCM
Karp Capital Management
Sausalito,
California
|
-$8.63M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6.52M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$6.25M |
| 5 |
NA
Navellier & Associates
Reno,
Nevada
|
-$5.85M |
FBT Hedge Fund Activity: Q2 2021 in Review
233 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2021, worth a combined $908M — down 1.4% from $921M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of FBT and 33 opened new positions — a net loss of 2 holders — while 91 trimmed existing stakes and 52 added.
The largest buyer was McGuire Investment Group, opening a new position worth an estimated $5.1M. The largest seller was Bank of America, cutting an estimated $8.72M.
- 233 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2021, down from 236 in Q1 2021.
- Funds reported $908M of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2021, down 1.4% quarter-over-quarter.
- 33 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2021 and 35 closed out, a net change of -2 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q2 2021 was McGuire Investment Group, an estimated $5.1M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q2 2021 was Bank of America, an estimated $8.72M sold.
Based on aggregated 13F filings for Q2 2021.